BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Clin Oncol. Jul 24, 2026; 17(7): 122037
Published online Jul 24, 2026. doi: 10.5306/wjco.122037
Table 4 Summary of guideline recommendations and practical implications
Guideline/source
Scope/context
Directness to adrenal metastases
Relevant message
AAES adrenalectomy guideline (2022)[54]General adrenal surgeryDirectMultidisciplinary team selection; biopsy rarely; resection may be offered to highly selected patients
ESE/ENSAT adrenal incidentaloma guideline (2023)[55]Adrenal mass evaluation in patients with extra-adrenal malignancyDirect for work-upMetanephrines; positron emission tomography/computerised tomography/surgery/biopsy if management changes; consider surgery if only metastasis
EAU RCC guideline (2024/2025)[56]Metastatic renal cell carcinomaDirect for renal cell carcinomaConsider metastasectomy/ablative therapy in favourable disease if complete resection is feasible
ESMO RCC guideline (2024)[57]Metastatic renal cell carcinomaDirect for renal cell carcinomaMetastasectomy not routine within 1 year of nephrectomy; local therapy in selected cases
SAGES adrenal pathology guideline (2013)[51]Operative approach to adrenalectomyIndirectMinimally invasive adrenalectomy preferred for suitable non-primary adrenal cancer pathology
NCCN Guidelines for Patients: Kidney Cancer (2025)[58]Patient-facing kidney cancer guidanceIndirect; renal cell carcinoma specificOligometastatic options include metastasectomy, radiation, or ablation


Write to the Help Desk